This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (49)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Michael A. Weber, MD; Jan I. M. Drayer, MD; F. Gilbert McMahon, MD; Robert Hamburger, MD; Arvindkumar R. Shah, MD; Lynne N. Kirk, MD

Arch Intern Med. 1984;144(6):1211-1213.

Abstract
• The effectiveness of transdermally administered clonidine hydrochloride was evaluated in a multicenter study in 85 patients with mild essential hypertension. The drug was incorporated into small self-adhesive delivery systems (pliable skin patches, 3.5—sq-cm area) designed to continuously deliver 0.1 mg of clonidine hydrochloride per day. These devices were changed by the patients themselves at weekly intervals. Diastolic BP fell by at least 10% in 37 patients and was normalized (<90 mm Hg) in 54 patients (64%); 17 of these responding patients required only one skin patch, 27 required two, and the other ten responders required three. The antihypertensive action of the transdermal clonidine was sustained for the full three months of study. Side effects were similar to those during conventional oral treatment, but appeared to be milder.

(Arch Intern Med 1984;144:1211-1213)

Author Affiliations
From the Veterans Administration Medical Centers, Long Beach, Calif (Drs Weber and Drayer), Boston (Dr Hamburger), and Cleveland (Dr Shah); the Clinical Research Center, New Orleans (Dr McMahon); and the University of Texas Health Science Center, Dallas (Dr Kirk).

Footnotes
Accepted for publication Nov 7, 1983.

Reprint requests to Veterans Administration Medical Center (W130), 5901 E Seventh St, Long Beach, CA 90822 (Dr Weber).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Behavioral and Physiologic Effects of Short-term and Long-term Administration of Clonidine in Panic Disorder
Uhde et al.
Arch Gen Psychiatry 1989;46:170-177.
ABSTRACT  

Effects of Transdermal Clonidine Treatment on Withdrawal Symptoms Associated With Smoking Cessation: A Randomized, Controlled Trial
Ornish et al.
Arch Intern Med 1988;148:2027-2031.
ABSTRACT  

Controlled-Release Therapeutic Systems: Technology Applicable To the Treatment of Oral Disease
Mirth
ADR 1987;1:109-118.
ABSTRACT  

Transdermal Effects of a Synthetic {alpha}-Melantropin/Corticotropin6-9 Analog in Multiple Sclerosis
Kiessling
Arch Neurol 1987;44:995-995.
ABSTRACT  

Transdermal Clonidine in Mild Hypertension A Randomized, Double-blind, Placebo-Controlled Trial
Popli et al.
Arch Intern Med 1986;146:2140-2144.
ABSTRACT